Filters

Ephrin B (Tyr324 + Tyr329) Antibody, FITC Conjugated

Ephrin B (Tyr324 + Tyr329) Antibody, FITC Conjugated size: 0.1ml 350

Supplier BIOSS PRIMARY CONJUGATED ANTIBODIES 1
Price 350
Size 0.1ml
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long name FITC Conjugated, Ephrin B (Tyr324 + Tyr329) Antibody
CategoryConjugated Primary Antibodies
ConjugationAnti-FITC Antibody
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenEphrin B Tyr324 + Tyr329
Specificity These phosphorylation sites are homologous to Tyr323 + Tyr328 in Mouse, This is a highly specific antibody against Ephrin B Tyr324 + Tyr329
ModificationPhosphorylation
Modification siteTyr324 + Tyr329
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
Immunogen_range300-346/346
Subcellular location Cell membrane, Cytoplasm
SourceKLH conjugated synthetic phosphopeptide derived from human Ephrin B around the phosphorylation site of Tyr324/329
Gene ID number1947
Swiss ProtP98172
Tested applicationsIF(IHC-P)
Recommended dilutionsIF(IHC-P)(1:50-200)
Crossreactivity Mouse, Human
Crossreactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Antigen background Binds promiscuously Eph receptors residing on adjacent cells, Binds to, Binds to, Binds to the receptor tyrosine kinases EPHB3 (preferred), Cell surface transmembrane ligand for Eph receptors, EPHB1 and EPHA1, May play a role in constraining the orientation of longitudinally projecting axons (By similarity), May play a role in constraining the orientation of longitudinally projecting axons (By similarity), The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling, a family of receptor tyrosine kinases which are crucial for migration, and induce the collapse of, and induce the collapse of, commissural axons/growth cones in vitro, commissural axons/growth cones in vitro, leading to contact-dependent bidirectional signaling into neighboring cells, repulsion and adhesion during neuronal, vascular and epithelial development, Binds to the receptor tyrosine kinases EPHB1 and EPHA1
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation Emission494nm/518nm
Synonyms CFNS, EFB1, EFL-3, EFL3, EFNB1, ELK ligand, EPH-related receptor tyrosine kinase ligand 2, EPLG2, Elk-L, Ephrin-B1, LERK-2, LERK2, CFND
Properties Bioss Primary Conjugated Antibodies FITC is highly sensitive to pH extremes, FITC has a green emission that's usually collected at 530 nanometers, FITC has a high quantum yield (efficiency of energy transfer from absorption to emission fluorescence) and approximately half of the absorbed photons are emitted as fluorescent light, For fluorescent microscopy applications, This Bioss Primary Conjugated Antibodies Fluorescein isothiocyanate (FITC) antibody is currently after some BD antibodies the most commonly used fluorescent dye for FACS, When excited at 488 nanometers, its photo bleaching effects are not observed due to a very brief interaction at the laser intercept, the 1 FITC is seldom used as it photo bleaches rather quickly though in flow cytometry applications, the FL1 detector of a FACSCalibur or FACScan, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
Gene targetEphrin B (Tyr324 + Tyr329) Conjugated
Short name FITC Conjugated, Ephrin B (Tyr324 + Tyr329) Antibody
Technique Fluorescein, antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelFITC
Alternative name fluorecein coupled, Ephrin B (Tyr324 and Tyr329) (Antibody to)
Alternative techniqueantibodies

Similar products

Subscribe to our Newsletter